Total properties:
47
|
|
Serial #:
|
|
Filing Dt:
|
04/03/2007
|
Reg #:
|
|
Reg. Dt:
|
11/04/2008
|
Mark:
|
AMERICAN HEALTH & DRUG BENEFITS
|
|
|
Serial #:
|
|
Filing Dt:
|
04/03/2007
|
Reg #:
|
|
Reg. Dt:
|
09/16/2008
|
Mark:
|
AMERICAN HEALTH & DRUG BENEFITS
|
|
|
Serial #:
|
|
Filing Dt:
|
06/11/2008
|
Reg #:
|
|
Reg. Dt:
|
05/05/2009
|
Mark:
|
INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY
|
|
|
Serial #:
|
|
Filing Dt:
|
07/02/2008
|
Reg #:
|
|
Reg. Dt:
|
12/30/2008
|
Mark:
|
THE ONCOLOGY PHARMACIST
|
|
|
Serial #:
|
|
Filing Dt:
|
07/02/2008
|
Reg #:
|
|
Reg. Dt:
|
12/30/2008
|
Mark:
|
THE ONCOLOGY PHARMACIST
|
|
|
Serial #:
|
|
Filing Dt:
|
01/11/2010
|
Reg #:
|
|
Reg. Dt:
|
02/08/2011
|
Mark:
|
VALUE-BASED CANCER CARE
|
|
|
Serial #:
|
|
Filing Dt:
|
01/11/2010
|
Reg #:
|
|
Reg. Dt:
|
02/08/2011
|
Mark:
|
VALUE-BASED CANCER CARE
|
|
|
Serial #:
|
|
Filing Dt:
|
08/09/2010
|
Reg #:
|
|
Reg. Dt:
|
09/06/2011
|
Mark:
|
THE JOURNAL OF ONCOLOGY NAVIGATION & SURVIVORSHIP
|
|
|
Serial #:
|
|
Filing Dt:
|
08/09/2010
|
Reg #:
|
|
Reg. Dt:
|
09/20/2011
|
Mark:
|
FOSTERING A DIALOGUE TO IMPROVE PATIENTCARE & OUTCOMES
|
|
|
Serial #:
|
|
Filing Dt:
|
01/10/2011
|
Reg #:
|
|
Reg. Dt:
|
08/16/2011
|
Mark:
|
THE ONCOLOGY NURSE-APN/PA
|
|
|
Serial #:
|
|
Filing Dt:
|
01/10/2011
|
Reg #:
|
|
Reg. Dt:
|
08/23/2011
|
Mark:
|
THE ONCOLOGY NURSE-APN/PA
|
|
|
Serial #:
|
|
Filing Dt:
|
01/10/2011
|
Reg #:
|
|
Reg. Dt:
|
08/23/2011
|
Mark:
|
THE ONCOLOGY NURSE-APN/PA
|
|
|
Serial #:
|
|
Filing Dt:
|
01/10/2011
|
Reg #:
|
|
Reg. Dt:
|
08/23/2011
|
Mark:
|
THE ONCOLOGY NURSE-APN/PA
|
|
|
Serial #:
|
|
Filing Dt:
|
03/02/2011
|
Reg #:
|
|
Reg. Dt:
|
02/12/2013
|
Mark:
|
RX PROFILER
|
|
|
Serial #:
|
|
Filing Dt:
|
03/02/2011
|
Reg #:
|
|
Reg. Dt:
|
08/07/2012
|
Mark:
|
RX PROFILER
|
|
|
Serial #:
|
|
Filing Dt:
|
03/10/2011
|
Reg #:
|
|
Reg. Dt:
|
02/16/2021
|
Mark:
|
ONCOLOGY PRACTICE MANAGEMENT
|
|
|
Serial #:
|
|
Filing Dt:
|
03/10/2011
|
Reg #:
|
|
Reg. Dt:
|
11/03/2020
|
Mark:
|
ONCOLOGY PRACTICE MANAGEMENT
|
|
|
Serial #:
|
|
Filing Dt:
|
03/10/2011
|
Reg #:
|
|
Reg. Dt:
|
11/03/2020
|
Mark:
|
ONCOLOGY PRACTICE MANAGEMENT
|
|
|
Serial #:
|
|
Filing Dt:
|
03/15/2011
|
Reg #:
|
|
Reg. Dt:
|
02/28/2012
|
Mark:
|
THE UROLOGY NURSE-NP/PA
|
|
|
Serial #:
|
|
Filing Dt:
|
03/15/2011
|
Reg #:
|
|
Reg. Dt:
|
02/28/2012
|
Mark:
|
THE UROLOGY NURSE-NP/PA
|
|
|
Serial #:
|
|
Filing Dt:
|
01/18/2012
|
Reg #:
|
|
Reg. Dt:
|
12/13/2016
|
Mark:
|
CONSIDERATIONS IN MULTIPLE MYELOMA
|
|
|
Serial #:
|
|
Filing Dt:
|
01/18/2012
|
Reg #:
|
|
Reg. Dt:
|
11/22/2016
|
Mark:
|
CONSIDERATIONS IN LYMPHOMA
|
|
|
Serial #:
|
|
Filing Dt:
|
02/08/2012
|
Reg #:
|
NONE
|
Reg. Dt:
|
|
Mark:
|
UROLOGY PRACTICE MANAGEMENT
|
|
|
Serial #:
|
|
Filing Dt:
|
02/08/2012
|
Reg #:
|
|
Reg. Dt:
|
09/20/2022
|
Mark:
|
UROLOGY PRACTICE MANAGEMENT
|
|
|
Serial #:
|
|
Filing Dt:
|
02/08/2012
|
Reg #:
|
NONE
|
Reg. Dt:
|
|
Mark:
|
UROLOGY PRACTICE MANAGEMENT
|
|
|
Serial #:
|
|
Filing Dt:
|
02/10/2012
|
Reg #:
|
|
Reg. Dt:
|
03/02/2021
|
Mark:
|
DERMATOLOGY PRACTICE MANAGEMENT
|
|
|
Serial #:
|
|
Filing Dt:
|
02/10/2012
|
Reg #:
|
|
Reg. Dt:
|
12/22/2020
|
Mark:
|
DERMATOLOGY PRACTICE MANAGEMENT
|
|
|
Serial #:
|
|
Filing Dt:
|
02/10/2012
|
Reg #:
|
|
Reg. Dt:
|
12/22/2020
|
Mark:
|
DERMATOLOGY PRACTICE MANAGEMENT
|
|
|
Serial #:
|
|
Filing Dt:
|
02/10/2012
|
Reg #:
|
|
Reg. Dt:
|
12/08/2020
|
Mark:
|
RHEUMATOLOGY PRACTICE MANAGEMENT
|
|
|
Serial #:
|
|
Filing Dt:
|
02/10/2012
|
Reg #:
|
|
Reg. Dt:
|
12/22/2020
|
Mark:
|
RHEUMATOLOGY PRACTICE MANAGEMENT
|
|
|
Serial #:
|
|
Filing Dt:
|
02/10/2012
|
Reg #:
|
NONE
|
Reg. Dt:
|
|
Mark:
|
RHEUMATOLOGY PRACTICE MANAGEMENT
|
|
|
Serial #:
|
|
Filing Dt:
|
12/05/2013
|
Reg #:
|
|
Reg. Dt:
|
06/02/2015
|
Mark:
|
IMMUNOTHERAPY IN ONCOLOGY
|
|
|
Serial #:
|
|
Filing Dt:
|
10/29/2014
|
Reg #:
|
|
Reg. Dt:
|
12/19/2017
|
Mark:
|
CONQUER
|
|
|
Serial #:
|
|
Filing Dt:
|
06/26/2020
|
Reg #:
|
NONE
|
Reg. Dt:
|
|
Mark:
|
STRATEGIX
|
|
|
Serial #:
|
|
Filing Dt:
|
06/26/2020
|
Reg #:
|
NONE
|
Reg. Dt:
|
|
Mark:
|
THE LYNX GROUP
|
|
|
Serial #:
|
|
Filing Dt:
|
07/14/2020
|
Reg #:
|
NONE
|
Reg. Dt:
|
|
Mark:
|
THE LYNX GROUP
|
|
|
Serial #:
|
|
Filing Dt:
|
07/14/2020
|
Reg #:
|
NONE
|
Reg. Dt:
|
|
Mark:
|
STRATEGIX
|
|
|
Serial #:
|
|
Filing Dt:
|
09/15/2020
|
Reg #:
|
|
Reg. Dt:
|
06/15/2021
|
Mark:
|
JOURNAL OF ONCOLOGY NAVIGATION & SURVIVORSHIP
|
|
|
Serial #:
|
|
Filing Dt:
|
09/15/2020
|
Reg #:
|
|
Reg. Dt:
|
06/15/2021
|
Mark:
|
JOURNAL OF ONCOLOGY NAVIGATION & SURVIVORSHIP
|
|
|
Serial #:
|
|
Filing Dt:
|
05/12/2021
|
Reg #:
|
|
Reg. Dt:
|
03/15/2022
|
Mark:
|
JOURNAL OF HEMATOLOGY ONCOLOGY PHARMACY
|
|
|
Serial #:
|
|
Filing Dt:
|
05/12/2021
|
Reg #:
|
|
Reg. Dt:
|
03/15/2022
|
Mark:
|
JOURNAL OF HEMATOLOGY ONCOLOGY PHARMACY
|
|
|
Serial #:
|
|
Filing Dt:
|
05/12/2021
|
Reg #:
|
|
Reg. Dt:
|
03/15/2022
|
Mark:
|
AMYLOIDOSISNEWS
|
|
|
Serial #:
|
|
Filing Dt:
|
06/17/2021
|
Reg #:
|
NONE
|
Reg. Dt:
|
|
Mark:
|
RESOURCE NAVIGATOR
|
|
|
Serial #:
|
|
Filing Dt:
|
06/22/2021
|
Reg #:
|
NONE
|
Reg. Dt:
|
|
Mark:
|
CONQUER THE PATIENT VOICE RARE DISEASE EDITION
|
|
|
Serial #:
|
|
Filing Dt:
|
06/26/2020
|
Reg #:
|
|
Reg. Dt:
|
03/29/2022
|
Mark:
|
STRATEGIX
|
|
|
Serial #:
|
|
Filing Dt:
|
07/14/2020
|
Reg #:
|
|
Reg. Dt:
|
03/29/2022
|
Mark:
|
STRATEGIX
|
|
|
Serial #:
|
|
Filing Dt:
|
12/03/2021
|
Reg #:
|
|
Reg. Dt:
|
01/16/2024
|
Mark:
|
IMMUNOTHERAPY IN ONCOLOGY
|
|